Amniotic fluid embolism: Pathophysiology and new strategies for management

Journal of Obstetrics and Gynaecology Research

Volumn 40, Issue 6, 2014, Pages 1507-1517

  Kanayama, Naohiro ^a   Tamura, Naoaki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

amniotic fluid embolism; anaphylactoid reaction; atonic bleeding; C1 esterase inhibitor; disseminated intravascular coagulation; rupture of the membranes; serum marker

Indexed keywords

ANTITHROMBIN; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FRESH FROZEN PLASMA; INTERLEUKIN 8; SIALYL TN ANTIGEN; UNCLASSIFIED DRUG; ZINC COPROPORPHYRIN 1;

AMNION FLUID EMBOLISM; ARTICLE; AUTOPSY; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME ACTIVITY; FATALITY; FLUID THERAPY; HUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; RESPIRATION CONTROL; SHOCK; THROMBOCYTE TRANSFUSION; ADULT; BLOOD; EMBOLISM, AMNIOTIC FLUID; FEMALE; LUNG; METABOLISM; PATHOLOGY; PREGNANCY; PRIMARY PREVENTION; RETROSPECTIVE STUDY; UTERUS;

ADULT; BIOLOGICAL MARKERS; COMPLEMENT C1 INHIBITOR PROTEIN; EMBOLISM, AMNIOTIC FLUID; FEMALE; HUMANS; LUNG; PREGNANCY; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; UTERUS;

EID: 84901842805     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12428     Document Type: Article

References (24)

1. Conde-Agudelo A, Romero R,. Amniotic fluid embolism: An evidence-based review. Am J Obstet Gynecol 2009; 201: 445 e1-445 13.
2. Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF,. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol 1995; 172 (4 Pt 1): 1158-1167, discussion 1167-9.
3. Tuffnell DJ,. United kingdom amniotic fluid embolism register. BJOG 2005; 112: 1625-1629.
4. Kanayama N, et al. Maternal death analysis from the Japanese autopsy registry for recent 16 years: Significance of amniotic fluid embolism. J Obstet Gynaecol Res 2011; 37: 58-63.
5. Knight M, Berg C, Brocklehurst P, et al. Amniotic fluid embolism incidence, risk factors and outcomes: A review and recommendations. BMC Pregnancy Childbirth 2012; 12: 7. doi: 10.1186/1471-2393-12-7.
6. Benson MD,. Anaphylactoid syndrome of pregnancy. Am J Obstet Gynecol 1996; 175 (3 Pt 1): 749.
7. Kretzschmar M, Zahm DM, Remmler K, Pfeiffer L, Victor L, Schirmeister W,. Pathophysiological and therapeutic aspects of amniotic fluid embolism (anaphylactoid syndrome of pregnancy): Case report with lethal outcome and overview. Anaesthesist 2003; 52: 419-426.
8. Gilmore DA, Wakim J, Secrest J, Rawson R,. Anaphylactoid syndrome of pregnancy: A review of the literature with latest management and outcome data. AANA J 2003; 71: 120-126.
9. Conde-Agudelo A, Romero R,. Amniotic fluid embolism: An evidence-based review. Am J Obstet Gynecol 2009; 201: 445.e1-445.13.
10. Clark SL,. Amniotic fluid embolism: Analysis of the national registry. Am J Obstet Gynecol 1995; 172 (4 Pt 1): 1158-1167. discussion 1167-9.
11. Courtney LD,. Amniotic fluid embolism. Obstet Gynecol Surv 1974; 29: 169-177.
12. Kanayama N, Yamazaki T, Naruse H, Sumimoto K, Horiuchi K, Terao T,. Determining zinc coproporphyrin in maternal plasma-A new method for diagnosing amniotic fluid embolism. Clin Chem 1992; 38: 526-529.
13. Kobayashi H, et al. A simple, non invasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc α 2-6GalNac. Am J Obstet Gynecol 1993; 168: 848-853.
14. Hikiji W, Tamura N, Shigeta A, Kanayama N, Fukunaga T,. Fatal amniotic fluid embolism with typical pathohistological, histochemical and clinical features. Forensic Sci Int 2013; 226: 16-19.
15. Kobayashi H, Ooi H, Hayakawa H, et al. Histological diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2-6GalNAc epitope. Hum Pathol 1997; 28: 428-433.
16. Legrand M, Rossignol M, Dreux S, et al. Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism. Crit Care Med 2012; 40: 2059-2063.
17. Benson MD, Kobayashi H, Silver RK, Oi H, Greenberger PA, Terao T,. Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 2001; 97: 510-514.
18. Benson MD,. Current concepts of immunology and diagnosis in amniotic fluid embolism. Clin Dev Immunol 2012; 2012: 946576.
19. Muller-Eberhard HJ,. Molecular organization and function of the complement system. Annu Rev Biochem 1988; 57: 321-347.
20. Schmaier AH, McCrae KR,. The plasma kallikrein-kinin system: Its evolution from contact activation. J Thromb Haemost 2007; 5: 2323-2329.
21. Kaplan AP, Ghebrehiwet B,. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol 2010; 47: 2161-2169.
22. Nzeako UC, Frigas E, Tremaine WJ,. Hereditary angioedema. Arch Intern Med 2001; 161: 2417-2429.
23. Cugno M, Cicardi M, Bottasso B, et al. Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 1997; 89: 3213-3218.
24. Tamura N, Kimura S, Farhana M, et al. C1 esterase inhibitor activity in amniotic fluid embolism. Crit Care Med 2014. [Epub ahead of print].